IDEXX Laboratories Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.IDEXX Laboratories Inc. (IDXX) shares fell 1.50% to $567.44 on Friday, underperforming the broader market and several key competitors including Johnson & Johnson, Medtronic, and Boston Scientific. This decline ended a two-day winning streak for the stock. Trading volume was below its 50-day average, and the stock remains significantly below its 52-week high.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of IDEXX Laboratories Inc. (IDXX) slid 1.50% to $567.44 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.01% to 7,457.69 and Dow Jones Industrial Average falling 0.77% to 52,146.42.
The stock's fall snapped a two-day winning streak.
IDEXX Laboratories Inc. closed 26.30% below its 52-week high of $769.98, which the company achieved on November 26th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 1.23% to $253.04, Medtronic PLC (MDT) fell 0.43% to $83.20, and Boston Scientific Corp. (BSX) fell 1.32% to $44.03.
Trading volume (504,840) remained 174,956 below its 50-day average volume of 679,796.
Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-17-26 1652ET